6家标杆企业亮相“X-Day”西丽湖路演社生命健康专场

Core Insights - The "X-Day" West Lake Roadshow focused on the life and health industry, including biomedicine, medical devices, and AI healthcare, aiming to integrate capital, industry, and innovation [1] - The event attracted over 40 health enterprises, showcasing 18 projects that received more than 400 institutional connection intentions [4][5] - Nanshan District is positioned as a leading area for biomedicine and high-end medical devices, with industry output value growing from 9.81 billion to 32.69 billion RMB over five years, reflecting a compound annual growth rate of 27.22% [6] Industry Highlights - The roadshow featured six benchmark companies and provided a platform for 12 high-potential projects in gene and cell therapy, nucleic acid drugs, AI and digital healthcare, and precision oncology [5] - Nanshan's biomedicine sector contributed 5.46 billion RMB to Shenzhen's GDP in 2024, accounting for 22% of the city's total, while the high-end medical device sector contributed 8.38 billion RMB, representing 27.4% of Shenzhen's total [6] - The event included a project display area for unpresented companies, facilitating direct communication between investors and entrepreneurs [7] Investment Trends - The event featured insights from eight industry experts on clinical value assessment, technology transfer, and global market strategies [7] - A report from QianKe Research Center indicated that the Greater Bay Area's equity investment market is outperforming national averages, with Nanshan achieving growth in 2024 [8] - The next "X-Day" event will focus on cornerstone investments in Hong Kong, continuing the initiative to connect capital with technology and industry [9]